Circio Holding ASA  logo

Circio Holding ASA

Developing novel circular RNA and immunotherapy medicines.

20 employees · est. 2010 · Oslo, Norway

VS
Ziphius logo

Ziphius

Diving deeper to uncover the possibilities of self-amplifying RNA.

60 employees · est. 2019 · Belgium

Circio Holding ASA is the older company (2010 vs 2019); Ziphius is the larger of the two.

Side-by-Side Comparison

Circio Holding ASA Ziphius
Founded
2010 older 2019
Headquarters
Oslo, Norway Belgium
Employees
20 60 larger
Industry
Biotechnology, Health Care Biotechnology, Pharmaceutical
Funding Stage
Post Ipo Debt Unknown
Total Funding
$262.30M $24.30M
Funding Rounds
5 1
Services
Not tracked yet Development of self-amplifying RNA technologies, Innovative solutions for infectious diseases, Advanced treatments for rare diseases, Next-generation oncology therapies, Custom lipid nanoparticle delivery systems
Target Customers
Not tracked yet Pharmaceutical companies, Researchers in biotechnology, Healthcare providers, Oncology specialists, Organizations focused on rare diseases
Taxonomy
Clinical Stage Company, Immunotherapy, Circular RNA, Vector-based Technology, Multi-functional CircRNA Medicines, RNA Therapeutics, Collaborative Clinical Trials, Oncolytic Adenovirus, Cancer Vaccine, Phase 2 Study, Healthcare Innovation Self-amplifying RNA, Biopharmaceutical, Vaccine Development, Infectious Disease Prevention, Next-generation Vaccines, RNA Technology, Biotech Innovation, Vaccine Biotechnology, Therapeutic RNA
Website
circio.com ziphius.org
Circio Holding ASA  logo

About Circio Holding ASA

Circio Holding ASA is a clinical stage company focused on developing immune activators to target difficult-to-treat diseases. The company's mission is to deploy vector-based technology to create a novel class of targeted, multi-functional circRNA medicines. It has established a cutting-edge circular...

Ziphius logo

About Ziphius

Ziphius, a Belgium-based company founded in 2019, operates in the Biotechnology and Pharmaceutical industries. Their mission, encapsulated in the slogan, "Diving deeper to uncover the possibilities of self-amplifying RNA," highlights their focus on innovative RNA technologies. This startup has capt...

We will tell you when either one moves

BounceWatch watches Circio Holding ASA and Ziphius for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Circio Holding ASA and Ziphius — by email.

Frequently Asked Questions

Circio Holding ASA — Developing novel circular RNA and immunotherapy medicines.. Ziphius — Diving deeper to uncover the possibilities of self-amplifying RNA.. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Circio Holding ASA has raised $262.30M while Ziphius has raised $24.30M.
Circio Holding ASA and Ziphius operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Circio Holding ASA with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Circio Holding ASA on 12 Sep 2024, and Ziphius on 11 Mar 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy